Caption Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-119,600
Closed -$190K 1182
2023
Q1
$190K Buy
+119,600
New +$617K ﹤0.01% 922
2022
Q3
Sell
-25,000
Closed -$159K 1599
2022
Q2
$159K Buy
+25,000
New +$142K ﹤0.01% 1261
2021
Q4
Sell
-15,000
Closed -$181K 1687
2021
Q3
$181K Sell
15,000
-125,300
-89% -$1.82M ﹤0.01% 1360
2021
Q2
$2.97M Buy
140,300
+17,800
+15% +$429K 0.04% 542
2021
Q1
$3.44M Buy
+122,500
New +$3.61M 0.07% 344
2020
Q4
Sell
-15,000
Closed -$558K 1061
2020
Q3
$558K Hold
15,000
0.01% 748
2020
Q2
$770K Sell
15,000
-12,000
-44% -$502K 0.03% 589
2020
Q1
$852K Sell
27,000
-3,000
-10% -$158K 0.05% 438
2019
Q4
$1.79M Hold
30,000
0.06% 375
2019
Q3
$1.1M Hold
30,000
0.06% 362
2019
Q2
$1.4M Buy
+30,000
New +$1.41M 0.07% 311
2019
Q1
Sell
-42,500
Closed -$1.96M 616
2018
Q4
$1.96M Sell
42,500
-107,500
-72% -$5.18M 0.16% 184
2018
Q3
$6.66M Buy
+150,000
New +$6.89M 0.37% 74

Other funds holding ESPR